# China HeadAche DIsorders RegiStry

> **NCT05334927** · — · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 10000 (estimated)

## Conditions studied

- Headache Disorders, Primary
- Migraine
- New Daily Persistent Headache
- Medication Overuse Headache
- Tension-Type Headache
- Trigeminal Autonomic Cephalalgia

## Interventions

- **BEHAVIORAL:** Medicine Overuse Headache/New Daily Persistent Headache
- **BEHAVIORAL:** Episodic Migraine and Chronic Migraine
- **BEHAVIORAL:** Patients with other types of primary headache
- **DRUG:** Yangxue Qingnao Granules (Pills)
- **BIOLOGICAL:** Erenumab
- **BIOLOGICAL:** Eptinezumab

## Key facts

- **NCT ID:** NCT05334927
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-29
- **Primary completion:** 2031-12-31
- **Final completion:** 2032-12-31
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05334927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05334927, "China HeadAche DIsorders RegiStry". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05334927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*